Exponent (EXPO) Releases Earnings Results, Beats Expectations By $0.08 EPS

Exponent (EXPO) announced its most recent quarterly financial results on Wednesday, Oct-19-2016. EXPO said it had a profit of $0.42 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.08. Analysts had a consensus of $0.34. The company posted revenue of $74.20 million in the period, compared to analysts expectations of $70.59 million. EXPO’s revenue was down -.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS.

Many Wall Street Analysts have commented on Exponent. Exponent was Initiated by Cantor Fitzgerald to “Buy” on Aug 26, 2016.

Exponent closed down -0.08 points or -0.16% at $48.7 with 72,277 shares getting traded on Friday. Post opening the session at $48.82, the shares hit an intraday low of $48.42 and an intraday high of $49.07 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

In a different news, on Aug 16, 2016, Paul Boehm (Group Vice President) sold 5,000 shares at $52.18 per share price. According to the SEC, on Aug 16, 2016, Robert D Caligiuri (Group Vice President) sold 1,300 shares at $51.67 per share price. On Jul 18, 2016, Paul R Johnston (President & CEO) sold 5,500 shares at $59.27 per share price, according to the Form-4 filing with the securities and exchange commission.

Exponent Inc. is a science and engineering consulting firm that provides solutions to complex problems. The Company serves clients in automotive aviation chemical construction consumer products energy Government health insurance manufacturing and technology among others. It provides engineering and scientific consulting services to clients around the world. It operates around 22 practices and centers in two operating segments: Engineering and Other Scientific and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics biomedical engineering buildings and structures construction consulting electrical engineering and computer science engineering management consulting thermal sciences and vehicle analysis services among others. Its Environmental and Health segment includes chemical regulation and food safety ecological and biological sciences environmental and earth sciences and mechanistic biology services among others.

Exponent

Leave a Reply

Exponent - Is it time to Sell?

Top Brokerage Firms are advising their investors on Exponent. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.